Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinyu Guo

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
European Journal of Nuclear Medicine and Molecular Imaging|June 13, 2023
Patlak-Ki derived from ultra-high sensitivity dynamic total body [<sup>18</sup>F]FDG PET/CT correlates with the response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer patientsDaQuan Wang, Bo Qiu, QianWen Liu, et al.
Current Oncology (Toronto, Ont.)|April 30, 2021
Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in <i>EGFR</i>-Mutant Stage III-pN2 Lung AdenocarcinomaQiwen Li, Li Ma, Bo Qiu, et al.
Practical Radiation Oncology|June 22, 2021
Hypofractionated Intensity Modulated Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer: A Phase II Prospective Clinical Trial (GASTO1011)Bo Qiu, Mai Xiong, YiFeng Luo, et al.
International Journal of Radiation Oncology, Biology, Physics|May 16, 2021
Moderately Hypofractionated Once-Daily Compared With Twice-Daily Thoracic Radiation Therapy Concurrently With Etoposide and Cisplatin in Limited-Stage Small Cell Lung Cancer: A Multicenter, Phase II, Randomized TrialBo Qiu, QiWen Li, JunLing Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 2, 2021
Hypo-fractionated radiotherapy with concurrent chemotherapy for locoregional recurrence of non-small cell lung cancer after complete resection: A prospective, single-arm, phase II study (GASTO-1017)NaiBin Chen, QiWen Li, SiYu Wang, et al.
Signal Transduction and Targeted Therapy|September 28, 2025
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trialBo Qiu, Yuanyuan Zhao, Wenzhuo He, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
European Journal of Nuclear Medicine and Molecular Imaging|June 13, 2023
Patlak-Ki derived from ultra-high sensitivity dynamic total body [<sup>18</sup>F]FDG PET/CT correlates with the response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer patientsDaQuan Wang, Bo Qiu, QianWen Liu, et al.
Current Oncology (Toronto, Ont.)|April 30, 2021
Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in <i>EGFR</i>-Mutant Stage III-pN2 Lung AdenocarcinomaQiwen Li, Li Ma, Bo Qiu, et al.
Practical Radiation Oncology|June 22, 2021
Hypofractionated Intensity Modulated Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer: A Phase II Prospective Clinical Trial (GASTO1011)Bo Qiu, Mai Xiong, YiFeng Luo, et al.
International Journal of Radiation Oncology, Biology, Physics|May 16, 2021
Moderately Hypofractionated Once-Daily Compared With Twice-Daily Thoracic Radiation Therapy Concurrently With Etoposide and Cisplatin in Limited-Stage Small Cell Lung Cancer: A Multicenter, Phase II, Randomized TrialBo Qiu, QiWen Li, JunLing Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 2, 2021
Hypo-fractionated radiotherapy with concurrent chemotherapy for locoregional recurrence of non-small cell lung cancer after complete resection: A prospective, single-arm, phase II study (GASTO-1017)NaiBin Chen, QiWen Li, SiYu Wang, et al.
Signal Transduction and Targeted Therapy|September 28, 2025
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trialBo Qiu, Yuanyuan Zhao, Wenzhuo He, et al.
Pageof 7